This is not surprising, since many studies have revealed the role of DVL3 in the pathogenesis and prognosis of different types of tumors, including colorectal cancer [36], liver cancer [37], lung adenocarcinoma [38], pancreatic adenocarcinoma [39], and prostate cancer [40]. This evidence concerns the gene DVL3 and pancreatic adenocarcinoma.